Stockreport

Biodesix outlines $106M–$112M 2026 revenue target as sales expansion drives 41% Q4 growth [Seeking Alpha]

Biodesix, Inc.  (BDSX) 
PDF CEO Scott Hutton indicated that Biodesix is prioritizing revenue growth, operational leverage, and pipeline advancement in 2025 and 2026. The company achieved a 41% rev [Read more]